Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Early Phase 1
1(16.7%)
6Total
N/A(5)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06296797Not ApplicableRecruiting

Patient-centered Information on Permanent Contraception

Role: collaborator

NCT06079060Not ApplicableCompleted

Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom

Role: collaborator

NCT05912283Not ApplicableCompleted

Evaluation of 2 Synthetic Nitrile Male Condoms Compared to a Standard Latex Male Condom

Role: collaborator

NCT05370196Not ApplicableCompleted

Synthetic Male Condom Slippage-Breakage Study

Role: collaborator

NCT04622306Not ApplicableCompleted

Evaluation of Polyurethane Male Condoms

Role: collaborator

NCT05308992Early Phase 1Unknown

User Preference Study of an Experimental HydroGlyde Male Condom Compared to a Commercial Latex Male Condom

Role: collaborator

All 6 trials loaded